Mengnan Zhao
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 13
- Cancer Genomics and Diagnostics 6
-
- Ferroptosis and cancer prognosis 18
- Lung Cancer Diagnosis and Treatment 14
- Lung Cancer Treatments and Mutations 12
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Molecular Biology top 10%
- RNA modifications and cancer 14
- Epigenetics and DNA Methylation 7
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Mengnan Zhao
64 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 533
- Pulmonary and Respiratory Medicine 744
- Oncology 570
- Molecular Biology 837
- Immunology 208
Countries citing papers authored by Mengnan Zhao
This map shows the geographic impact of Mengnan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengnan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengnan Zhao more than expected).
Fields of papers citing papers by Mengnan Zhao
This network shows the impact of papers produced by Mengnan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengnan Zhao. The network helps show where Mengnan Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengnan Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 37 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 26 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 30 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 75 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 25 | |
| 16 | 2021 | 30 | |
| 17 | 2021 | 10 | |
| 18 | 2020 | 23 | |
| 19 | 2019 | 12 | |
| 20 | 2019 | 19 |
About Mengnan Zhao
Mengnan Zhao is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (18 papers), Lung Cancer Diagnosis and Treatment (14 papers), RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (13 papers), Lung Cancer Treatments and Mutations (12 papers), Epigenetics and DNA Methylation (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (533 citations), Pulmonary and Respiratory Medicine (744 citations) and Oncology (570 citations). Mengnan Zhao has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Cheng Zhan, Qun Wang, Yiwei Huang, Tao Lu, Ming Li, Xiaodong Yang, Jiaqi Liang, Zhencong Chen, Jiacheng Yin and Guoshu Bi. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.